American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part I.
Kneller
Sian
S
Thomson Scientific, The Johnson Building, 77 Hatton Garden, London, EC1N 8JS, UK. sian.kneller@thomson.com
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011355:Prodrugs / Q000627:therapeutic use*; D012106:Research; D050257:Tubulin Modulators / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D011355:Prodrugs; D050257:Tubulin Modulators